Literature DB >> 26046974

DNA damage in Fabry patients: An investigation of oxidative damage and repair.

Giovana Brondani Biancini1, Dinara Jaqueline Moura2, Paula Regina Manini2, Jéssica Lamberty Faverzani3, Cristina Brinckmann Oliveira Netto3, Marion Deon3, Roberto Giugliani1, Jenifer Saffi2, Carmen Regla Vargas4.   

Abstract

Fabry disease (FD) is a lysosomal storage disorder associated with loss of activity of the enzyme α-galactosidase A. In addition to accumulation of α-galactosidase A substrates, other mechanisms may be involved in FD pathophysiology, such as inflammation and oxidative stress. Higher levels of oxidative damage to proteins and lipids in Fabry patients were previously reported. However, DNA damage by oxidative species in FD has not yet been studied. We investigated basal DNA damage, oxidative DNA damage, DNA repair capacity, and reactive species generation in Fabry patients and controls. To measure oxidative damage to purines and pyrimidines, the alkaline version of the comet assay was used with two endonucleases, formamidopyrimidine DNA-glycosylase (FPG) and endonuclease III (EndoIII). To evaluate DNA repair, a challenge assay with hydrogen peroxide was performed. Patients presented significantly higher levels of basal DNA damage and oxidative damage to purines. Oxidative DNA damage was induced in both DNA bases by H2O2 in patients. Fabry patients presented efficient DNA repair in both assays (with and without endonucleases) as well as significantly higher levels of oxidative species (measured by dichlorofluorescein content). Even if DNA repair be induced in Fabry patients (as a consequence of continuous exposure to oxidative species), the repair is not sufficient to reduce DNA damage to control levels.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA damage; DNA repair; Fabry disease; Oxidative stress; Reactive species

Mesh:

Substances:

Year:  2015        PMID: 26046974     DOI: 10.1016/j.mrgentox.2015.04.012

Source DB:  PubMed          Journal:  Mutat Res Genet Toxicol Environ Mutagen        ISSN: 1383-5718            Impact factor:   2.873


  7 in total

1.  Imbalanced Production of Reactive Oxygen Species and Mitochondrial Antioxidant SOD2 in Fabry Disease-Specific Human Induced Pluripotent Stem Cell-Differentiated Vascular Endothelial Cells.

Authors:  Wei-Lien Tseng; Shih-Jie Chou; Huai-Chih Chiang; Mong-Lien Wang; Chian-Shiu Chien; Kuan-Hsuan Chen; Hsin-Bang Leu; Chien-Ying Wang; Yuh-Lih Chang; Yung-Yang Liu; Yuh-Jyh Jong; Shinn-Zong Lin; Shih-Hwa Chiou; Shing-Jong Lin; Wen-Chung Yu
Journal:  Cell Transplant       Date:  2016-12-06       Impact factor: 4.064

2.  Serum Bilirubin Levels and Promoter Variations in HMOX1 and UGT1A1 Genes in Patients with Fabry Disease.

Authors:  Alena Jirásková; Giulia Bortolussi; Gabriela Dostálová; Lenka Eremiášová; Lubor Golaň; Vilém Danzig; Aleš Linhart; Libor Vítek
Journal:  Oxid Med Cell Longev       Date:  2017-08-16       Impact factor: 6.543

3.  Can Be miR-126-3p a Biomarker of Premature Aging? An Ex Vivo and In Vitro Study in Fabry Disease.

Authors:  Alessia Lo Curto; Simona Taverna; Maria Assunta Costa; Rosa Passantino; Giuseppa Augello; Giorgia Adamo; Anna Aiello; Paolo Colomba; Carmela Zizzo; Marco Zora; Giulia Accardi; Giuseppina Candore; Daniele Francofonte; Tiziana Di Chiara; Riccardo Alessandro; Calogero Caruso; Giovanni Duro; Giuseppe Cammarata
Journal:  Cells       Date:  2021-02-09       Impact factor: 6.600

4.  Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy.

Authors:  Li Fu; Sylwia Wasiak; Laura M Tsujikawa; Brooke D Rakai; Stephanie C Stotz; Norman C W Wong; Jan O Johansson; Michael Sweeney; Connie M Mohan; Aneal Khan; Ewelina Kulikowski
Journal:  Pharmacol Res Perspect       Date:  2022-06

5.  Increased Serum Interleukin-6 and Tumor Necrosis Factor Alpha Levels in Fabry Disease: Correlation with Disease Burden.

Authors:  Nilton Salles Rosa Neto; Judith Campos de Barros Bento; Valéria de Falco Caparbo; Rosa Maria Rodrigues Pereira
Journal:  Clinics (Sao Paulo)       Date:  2021-07-16       Impact factor: 2.365

Review 6.  Rare disease landscape in Brazil: report of a successful experience in inborn errors of metabolism.

Authors:  Roberto Giugliani; Filippo P Vairo; Mariluce Riegel; Carolina F M de Souza; Ida V D Schwartz; Sérgio D J Pena
Journal:  Orphanet J Rare Dis       Date:  2016-06-10       Impact factor: 4.123

7.  Cardiac manifestations in patients with classical or cardiac subtype of Fabry disease.

Authors:  Wei-Ting Wang; Shih-Hsien Sung; Jo-Nan Liao; Ting-Rong Hsu; Dau-Ming Niu; Wen-Chung Yu
Journal:  J Chin Med Assoc       Date:  2020-09       Impact factor: 3.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.